Shopping Cart
- Remove All
- Your shopping cart is currently empty
AVG-233 is an orally available RNA-dependent RNA polymerase (RdRp) inhibitor with antiviral activity that blocks respiratory syncytial virus and SARS-CoV-2 replication.AVG-233 is used in the study of respiratory syncytial virus infections.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $199 | In Stock |
Description | AVG-233 is an orally available RNA-dependent RNA polymerase (RdRp) inhibitor with antiviral activity that blocks respiratory syncytial virus and SARS-CoV-2 replication.AVG-233 is used in the study of respiratory syncytial virus infections. |
In vitro | AVG-233 (20 μM) exhibits nanomolar activity against both laboratory-adapted RSV strains and clinical RSV isolates[1]. |
In vivo | In female Balb/cJ mice with recRSV-mKate xenograft, AVG-233 (50 and 100 mg/kg; oral gavage; once) reduced lung viral load by 0.89 log10 TCID50 (median tissue culture infectious dose)/mL[2]. |
Molecular Weight | 487.94 |
Formula | C26H22ClN5O3 |
Cas No. | 2151937-80-1 |
Storage | keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 30 mg/mL (61.48 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.